OppenheimerFunds Inc. Reduces Position in Brink’s (BCO)

Share on StockTwits

OppenheimerFunds Inc. reduced its stake in shares of Brink’s (NYSE:BCO) by 4.9% in the first quarter, Holdings Channel reports. The institutional investor owned 11,440 shares of the business services provider’s stock after selling 592 shares during the period. OppenheimerFunds Inc.’s holdings in Brink’s were worth $863,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently modified their holdings of the company. ETF Managers Group LLC lifted its stake in Brink’s by 7.9% in the 1st quarter. ETF Managers Group LLC now owns 2,013 shares of the business services provider’s stock worth $152,000 after acquiring an additional 148 shares in the last quarter. Arizona State Retirement System increased its position in Brink’s by 0.4% in the 4th quarter. Arizona State Retirement System now owns 36,329 shares of the business services provider’s stock worth $2,349,000 after purchasing an additional 151 shares during the last quarter. Falcon Point Capital LLC increased its position in Brink’s by 0.3% in the 1st quarter. Falcon Point Capital LLC now owns 50,019 shares of the business services provider’s stock worth $3,772,000 after purchasing an additional 153 shares during the last quarter. US Bancorp DE increased its position in Brink’s by 3.1% in the 1st quarter. US Bancorp DE now owns 6,229 shares of the business services provider’s stock worth $469,000 after purchasing an additional 190 shares during the last quarter. Finally, SG Americas Securities LLC increased its position in Brink’s by 3.6% in the 1st quarter. SG Americas Securities LLC now owns 6,405 shares of the business services provider’s stock worth $483,000 after purchasing an additional 222 shares during the last quarter. Hedge funds and other institutional investors own 98.36% of the company’s stock.

In related news, EVP Amit Zukerman sold 5,000 shares of the firm’s stock in a transaction that occurred on Monday, April 29th. The stock was sold at an average price of $80.00, for a total transaction of $400,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Ronald James Domanico bought 3,000 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The shares were bought at an average price of $72.39 per share, with a total value of $217,170.00. The disclosure for this purchase can be found here. In the last quarter, insiders acquired 18,000 shares of company stock valued at $1,309,720 and sold 37,844 shares valued at $3,032,561. 1.05% of the stock is currently owned by company insiders.

Separately, Zacks Investment Research lowered Brink’s from a “hold” rating to a “sell” rating in a report on Tuesday, April 9th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $96.67.

BCO traded up $0.96 during midday trading on Friday, reaching $79.08. The company’s stock had a trading volume of 329,352 shares, compared to its average volume of 358,778. The firm has a market capitalization of $3.94 billion, a P/E ratio of 22.86, a price-to-earnings-growth ratio of 1.30 and a beta of 1.57. The company has a quick ratio of 1.37, a current ratio of 1.37 and a debt-to-equity ratio of 8.90. Brink’s has a twelve month low of $59.08 and a twelve month high of $86.34.

Brink’s (NYSE:BCO) last released its earnings results on Wednesday, April 24th. The business services provider reported $0.79 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.72 by $0.07. The firm had revenue of $905.00 million for the quarter, compared to analyst estimates of $914.08 million. Brink’s had a positive return on equity of 86.38% and a negative net margin of 1.19%. The company’s revenue was up 6.1% on a year-over-year basis. During the same quarter last year, the firm posted $0.65 EPS. As a group, analysts anticipate that Brink’s will post 4.22 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 3rd. Shareholders of record on Friday, May 17th will be issued a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a yield of 0.76%. The ex-dividend date of this dividend is Thursday, May 16th. Brink’s’s dividend payout ratio (DPR) is currently 17.34%.

TRADEMARK VIOLATION NOTICE: “OppenheimerFunds Inc. Reduces Position in Brink’s (BCO)” was first reported by Zolmax and is the property of of Zolmax. If you are accessing this piece on another site, it was stolen and republished in violation of U.S. & international trademark and copyright law. The legal version of this piece can be viewed at https://zolmax.com/investing/oppenheimerfunds-inc-reduces-position-in-brinks-bco/3095090.html.

About Brink’s

The Brink's Company provides secure transportation, cash management, and other security-related services in North America, South America, and internationally. The company offers cash-in-transit services, including armored vehicle transportation of valuables; automated teller machine (ATM) services, such as cash replenishment, replenishment forecasting, cash optimization, ATM remote monitoring, service call dispatching, transaction processing, installation, and first and second line maintenance; and network infrastructure services.

Recommended Story: Understanding Analyst Ratings

Want to see what other hedge funds are holding BCO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Brink’s (NYSE:BCO).

Institutional Ownership by Quarter for Brink`s (NYSE:BCO)

Receive News & Ratings for Brink's Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brink's and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Genomic Health, Inc.  Insider Sells $161,677.53 in Stock
Genomic Health, Inc. Insider Sells $161,677.53 in Stock
Nektar Therapeutics  CEO Howard W. Robin Sells 12,551 Shares
Nektar Therapeutics CEO Howard W. Robin Sells 12,551 Shares
Extra Space Storage, Inc.  EVP James Overturf Sells 3,103 Shares
Extra Space Storage, Inc. EVP James Overturf Sells 3,103 Shares
VikkyToken   Trading 16.9% Lower  Over Last 7 Days
VikkyToken Trading 16.9% Lower Over Last 7 Days
Bloom  Price Hits $0.0517 on Major Exchanges
Bloom Price Hits $0.0517 on Major Exchanges
GINcoin  Reaches 1-Day Volume of $22,992.00
GINcoin Reaches 1-Day Volume of $22,992.00


 
© 2006-2019 Zolmax.